These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18519765)

  • 1. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
    Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
    Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.
    Teixeira AL; Ribeiro R; Morais A; Lobo F; Fraga A; Pina F; Calais-da-Silva FM; Calais-da-Silva FE; Medeiros R
    Pharmacogenomics J; 2009 Oct; 9(5):341-6. PubMed ID: 19488063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
    Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
    DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration.
    Fraga A; Ribeiro R; Príncipe P; Lobato C; Pina F; Maurício J; Monteiro C; Sousa H; Calais da Silva F; Lopes C; Medeiros R
    Eur J Cancer; 2014 Jan; 50(2):359-65. PubMed ID: 24090974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene.
    Araújo AP; Ribeiro R; Pereira D; Pinto D; Sousa B; Catarino R; Medeiros R
    Exp Biol Med (Maywood); 2009 Mar; 234(3):241-5. PubMed ID: 19144868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.
    Ross RW; Oh WK; Xie W; Pomerantz M; Nakabayashi M; Sartor O; Taplin ME; Regan MM; Kantoff PW; Freedman M
    J Clin Oncol; 2008 Feb; 26(6):842-7. PubMed ID: 18281655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between functional EGF+61 polymorphism and glioma risk.
    Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
    Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
    Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
    Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
    Langsenlehner T; Langsenlehner U; Renner W; Kapp KS; Krippl P; Hofmann G; Clar H; Pummer K; Mayer R
    Prostate; 2008 Feb; 68(3):264-8. PubMed ID: 18163425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.
    Almeida LO; Custódio AC; Santos MJ; Almeida JR; Clara CA; Pinto GR; Rey JA; Casartelli C
    Cancer Genet Cytogenet; 2010 Apr; 198(1):15-21. PubMed ID: 20303009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
    James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
    Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms leading to the development of hormone-resistant prostate cancer.
    Kasper S; Cookson MS
    Urol Clin North Am; 2006 May; 33(2):201-10, vii. PubMed ID: 16631458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
    Chen RC; Sadetsky N; Chen MH; Carroll PR; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):36-9. PubMed ID: 19233568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
    Hamai Y; Matsumura S; Matsusaki K; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Toge T; Yasui W
    Pathobiology; 2005; 72(3):133-8. PubMed ID: 15860930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
    Lim YJ; Kim JW; Song JY; Hong MS; Jin SY; Yoon SH; Park HJ; Choe BK; Lee JJ; Yim SV; Hong SI; Baik HH; Ha E; Park YH
    Neurosci Lett; 2005 Feb; 374(3):157-60. PubMed ID: 15663953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.